SML2213
Synonym(s):
(4R)-1,3,4,5-Tetrahydro-4-methyl-6-[1-methyl-3-(1-methyl-1H-pyrazol-4-yl)-1H-indazol-5-yl]-2H-1,5-benzodiazepin-2-one, (4R)-4-Methyl-6-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one, 2H-1,5-Benzodiazepin-2-one, 1,3,4,5-tetrahydro-4-methyl-6-[1-methyl-3-(1-methyl-1H-pyrazol-4-yl)-1H-indazol-5-yl]-, (4R)-, CPI 637
Properties
≥98% (HPLC)
powder
[α]/D -39 to -49°, c = 1.0 in chloroform-d
white to beige
DMSO: 2 mg/mL, clear
−20°C
[n]1(ncc(c1)c2n[n](c3c2cc(cc3)c4c5c(ccc4)NC(=O)C[C@H](N5)C)C)C
1S/C22H22N6O/c1-13-9-20(29)25-18-6-4-5-16(22(18)24-13)14-7-8-19-17(10-14)21(26-28(19)3)15-11-23-27(2)12-15/h4-8,10-13,24H,9H2,1-3H3,(H,25,29)/t13-/m1/s1
BFTKDWYIRJGJCA-CYBMUJFWSA-N
Description
Show Differences
1 of 1
Sigma-Aldrich
CPI-637
SML1781
PDD00017273
SML1333
Pimobendan
SML2384
BAY 87-2243
2-8°C
DMSO: 10 mg/mL, clear
DMSO: 5 mg/mL, clear (warmed)
-
11 - Combustible Solids
WGK 3
Not applicable
Choose from one of the most recent versions:
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.
If you need assistance, please contact Customer Support
Find documentation for the products that you have recently purchased in the Document Library.
Visit the Document Library
Related Categories
Bioactive Small Molecule Inhibitors